Terms: = Pancreatic cancer AND MEN1, ENSG00000133895, 4221
787 results:
1. Combined deletion of men1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
Fuentes ME; Lu X; Flores NM; Hausmann S; Mazur PK
Sci Rep; 2024 Apr; 14(1):8510. PubMed ID: 38609433
[TBL] [Abstract] [Full Text] [Related]
2. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract] [Full Text] [Related]
3. Genetic disorders and insulinoma/glucagonoma.
Marini F; Giusti F; Brandi ML
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
[TBL] [Abstract] [Full Text] [Related]
4. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
5. Intraoperative segmental pancreatic occlusion and insulin assay combination optimizes the localization of lesions and confirmation of complete resection in pancreatic hypoglycemia patients.
Atyah MM; Huang J; Yang Z
Surgery; 2024 Apr; 175(4):1147-1153. PubMed ID: 38267341
[TBL] [Abstract] [Full Text] [Related]
6. Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.
Cowzer D; Shah RH; Chou JF; Kundra R; Punn S; Fiedler L; DeMore A; Capanu M; Berger MF; Reidy-Lagunes D; Raj N
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38252063
[TBL] [Abstract] [Full Text] [Related]
7. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract] [Full Text] [Related]
8. [Individualized approach for men1-associated duodenopancreatic neuroendocrine neoplasms].
Manoharan J; Albers MB; Bartsch DK
Chirurgie (Heidelb); 2024 Mar; 95(3):207-215. PubMed ID: 38180518
[TBL] [Abstract] [Full Text] [Related]
9. [Multiple neuroendocrine tumors of the pancreas].
Sipos B
Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
[TBL] [Abstract] [Full Text] [Related]
10. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract] [Full Text] [Related]
11. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
12. Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?
Jannin A; Dessein AF; Do Cao C; Vantyghem MC; Chevalier B; Van Seuningen I; Jonckheere N; Coppin L
Front Endocrinol (Lausanne); 2023; 14():1248575. PubMed ID: 37908747
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Case Report of Non-Diabetic Hypoglycemia Due to a Combination of Germline Mutations in the
Yukina M; Solodovnikova E; Popov S; Zakharova V; Utkina M; Petrov V; Troshina E; Mokrysheva N
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895301
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas.
Vesterinen T; Peltola E; Leijon H; Hannula P; Huhtala H; Mäkinen MJ; Nieminen L; Pirinen E; Rönty M; Söderström M; Jaatinen P; Arola J
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894845
[TBL] [Abstract] [Full Text] [Related]
15. Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review.
Gao Y; Li R; Wu L; Yang H; Mao J; Zhao W
Endocrine; 2023 Nov; 82(2):442-449. PubMed ID: 37668926
[TBL] [Abstract] [Full Text] [Related]
16. A Japanese Family Meeting the Clinical Diagnostic Criteria for men1 with a men1 Variant of Uncertain Significance.
Matsubayashi H; Kiyozumi Y; Harada R; Mukaigawa T; Sugiura T; Ishiwatari H; Sato J; Niiya F; Nakashima K; Kado N; Nishimura S; Honda G; Ohike N
Intern Med; 2024 Apr; 63(8):1119-1123. PubMed ID: 37661450
[TBL] [Abstract] [Full Text] [Related]
17. [Indication and Surgical Procedures for men1-associated Duodenopancreatic Neuroendocrine Neoplasms].
Manoharan J; Albers M; Bartsch DK
Zentralbl Chir; 2023 Dec; 148(6):483-491. PubMed ID: 37604166
[TBL] [Abstract] [Full Text] [Related]
18. Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story.
Faggiano A
J Endocrinol Invest; 2024 Jan; 47(1):35-46. PubMed ID: 37581846
[TBL] [Abstract] [Full Text] [Related]
19. Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic men1 inactivation arisen during immunotherapy.
Mastrosimini MG; Mafficini A; Tondulli L; Milella M; Piccoli P; Mattiolo P; Fassan M; Hong SM; Scarpa A; Luchini C
Virchows Arch; 2023 Sep; 483(3):415-419. PubMed ID: 37581694
[TBL] [Abstract] [Full Text] [Related]
20. Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography.
Said M; Krogh J; Feldt-Rasmussen U; Rasmussen ÅK; Kristensen TS; Rossing CM; Johannesen HH; Oturai P; Holmager P; Kjaer A; Klose M; Langer S; Knigge U; Andreassen M
J Neuroendocrinol; 2023 Aug; 35(8):e13322. PubMed ID: 37564005
[TBL] [Abstract] [Full Text] [Related]
[Next]
